MAPT and Alzheimer disease: In this study, the three biomarkers (α4β2* nAChRs, Aβ plaques and Tau) were evaluated in HP-SUB brains regions from CN and AD subjects using autoradiography to assess potential relationships between these biomarkers in AD.